Alzheon Obtains $1,300,000 New Financing Round

  • Feed Type
  • Date
    2/29/2016
  • Company Name
    Alzheon
  • Mailing Address
    111 Speen Street Framingham, MA 01701 USA
  • Company Description
    Alzheon is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurodegenerative disorders.
  • Website
    http://www.alzheon.com
  • Transaction Type
    Debt
  • Transaction Amount
    $1,300,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed. 3 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
  • M&A Terms
  • Venture Investor
    Undisclosed